Diasorin SpA DIA

Morningstar Rating
€103.30 −1.65 (1.57%)
View Full Chart

Company Report

Price vs Fair Value

DIA is trading at a 867% premium.
Price
€104.95
Fair Value
€414.00
Uncertainty
Medium
1-Star Price
€831.54
5-Star Price
€81.20
Economic Moat
Xsqvmf
Capital Allocation
Dyccgjw

Bulls Say, Bears Say

Bulls

DiaSorin has niche expertise in infectious diseases, especially immunodiagnostics where it is a leader in chemiluminescence platforms, and is building its position in molecular diagnostics.

Bears

Near-term margins have been under pressure due to various factors, including launches of new products, the integration of Luminex, inflationary pressures, and elevated research and development costs.

Trading Information

Previous Close Price
€104.95
Day Range
€103.10105.05
52-Week Range
€81.24107.10
Bid/Ask
€103.25 / €103.30
Market Cap
€5.51 Bil
Volume/Avg
16,974 / 115,653

Key Statistics

Price/Earnings (Normalized)
21.42
Price/Sales
5.03
Dividend Yield (Trailing)
1.10%
Dividend Yield (Forward)
1.10%
Total Yield
1.43%

Company Profile

DiaSorin, headquartered in Italy, is a global provider of in vitro diagnostics, or IVD, which refers to testing done on samples taken from the human body, such as blood and tissue. DiaSorin produces and markets testing reagent kits for immunodiagnostics (about 65% of total sales) and molecular diagnostics (about 20%) and has a total installed base of about 9,000 diagnostic systems. Instruments and other revenue contribute about 15% of total sales. DiaSorin’s largest market in 2023 was North America, which accounted for 48% of non-covid revenue, followed by Europe (35%) and the Rest of the World (18%).
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Mid Growth
Total Number of Employees
3,186

Competitors

Valuation

Metric
DIA
BIM
BIO
Price/Earnings (Normalized)
21.4225.1731.64
Price/Book Value
3.463.331.43
Price/Sales
5.033.383.84
Price/Cash Flow
18.2219.7110.01
Price/Earnings
DIA
BIM
BIO

Financial Strength

Metric
DIA
BIM
BIO
Quick Ratio
1.671.204.23
Current Ratio
3.122.216.28
Interest Coverage
10.3595.74−35.80
Quick Ratio
DIA
BIM
BIO

Profitability

Metric
DIA
BIM
BIO
Return on Assets (Normalized)
6.48%9.17%2.66%
Return on Equity (Normalized)
12.05%12.83%3.75%
Return on Invested Capital (Normalized)
10.14%11.23%2.93%
Return on Assets
DIA
BIM
BIO

Diagnostics & Research Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
DgbjzdnwLmh$234.1 Bil
Danaher Corp
DHR
BflqmxlysRgjfcj$197.8 Bil
IQVIA Holdings Inc
IQV
YqqjtqqyGtpnkl$42.2 Bil
Agilent Technologies Inc
A
DwyqlfyhjpQmpz$42.1 Bil
IDEXX Laboratories Inc
IDXX
RtmztjbdPdhw$40.0 Bil
Mettler-Toledo International Inc
MTD
PcszmzrlfJklfwp$31.8 Bil
Icon PLC
ICLR
LgbhqhfyCrbmgsq$24.4 Bil
Illumina Inc
ILMN
FhlsfzvfwTvwhc$22.1 Bil
Waters Corp
WAT
ZcvxdggqVzzbh$21.1 Bil
Labcorp Holdings Inc
LH
RfjhfkhpwFrbrxkd$18.4 Bil

Sponsor Center